INTRODUCTION
Viral infection of host cells activates a potent innate immune response that, unless actively subverted by the invading virus, results in the establishment of an antiviral state capable of restricting viral replication and subsequent spread to other host cells (
1–3). In most nonimmune cells, this antiviral state is characterized by activation of a transcriptional program that leads to the expression of hundreds of antiviral genes (
4). Type I interferons (IFNs), which are secreted from infected cells and bind their cognate receptors in both an autocrine and paracrine manner, are early critical mediators of this host antiviral program in most cell types. The presence of virus in host cells is detected by a variety of distinct membrane-bound or cytoplasmic pattern recognition receptors (PRRs) that bind to pathogen-associated molecular patterns (PAMPs) including double-stranded RNA (dsRNA) and the phosphate and methyl moieties on viral RNA (
2). Ligand-activated PRRs mediate the assembly of signaling complexes that ultimately result in the activation of the transcription factors IFN regulatory factor 3 (IRF3) and NF-κB, both of which are required for the induction of type I IFNs (
5). During this early phase of infection, IRF3 and NF-κB activated by the presence of virus also mediate the transcription of several unique and overlapping sets of virus stress-induced genes (VSIGs) (
6). Interferon secreted from these initially infected cells binds and activates IFN receptors, triggering a signaling cascade that results in the expression of numerous interferon-stimulated genes (ISGs) and synthesis of secondary IFN subtypes in activated cells (
1,
4). The transcription of a majority of ISGs is critically dependent on IFN receptor-mediated activation of the transcription factor signal transducer and activator of transcription 1 (STAT1) as a result of its recruitment to the IFN receptor and subsequent phosphorylation at a tyrosine residue (Y701) by Janus-activated kinase (JAK) (
7). The phosphorylation of STAT1 at Y701 leads to the formation of a heterotrimeric complex of STAT1, STAT2, and IRF9; this complex, called interferon-stimulated gene factor 3 (ISGF3), induces the transcription of antiviral ISGs containing the STAT-responsive interferon-stimulated response element (ISRE) and/or gamma-activated sequence (GAS) promoter elements (
8,
9).
Rotavirus (RV) is a nonenveloped icosahedral member of the
Reoviridae family with a segmented dsRNA genome that encodes a total of six nonstructural and six structural proteins (
10). Rotaviruses replicate predominantly in mature villous enterocytes of the small intestine and cause severe dehydrating diarrhea in infants and children below the age of 5 years, accounting for ∼450,000 deaths annually (
11). In addition to their importance as human pathogens, rotaviruses also infect and cause diarrheal disease in the young of many other mammalian species. One approach to rotavirus vaccine development exploits the natural attenuation of rotaviruses in a heterologous host species (i.e., a species that is not the usual host) (
12). This host range restriction (HRR) is likely to be multifactorial, and several lines of evidence suggest that STAT1-dependent innate immune responses are one of the factors that restrict replication of heterologous RV at intestinal and systemic sites (
13–18). In young children, a heterologous simian and two heterologous bovine RV strains are substantially attenuated for replication in the gut (
19). In the suckling mouse model, the heterologous simian rotavirus RRV replicates poorly in the gut compared to the homologous murine EW strain (∼10
4-fold less well), and this restriction of RRV is significantly alleviated in mice lacking the type I/II IFN receptors or STAT1 (∼10
2- to 10
3-fold increase relative to replication in wild-type mice) (
14,
20). In contrast to the IFN-sensitive replication of the heterologous simian RRV, the homologous murine EW RV strain replicates to high titers in the suckling mouse intestine and is only modestly enhanced (∼10
1-fold) in the absence of type I/II IFN receptors or STAT1 (
14,
20).
As opposed to the IFN-dependent phenotypes of heterologous RV replication
in vivo, most RV strains studied so far (e.g., simian RRV) are capable of inhibiting the induction of IFN
in vitro (
15,
21,
22). However, certain exceptions have been reported, including the bovine UK rotavirus strain in murine fibroblasts (
15,
23) and several isolates of RV that encode truncated NSP1 proteins and form small plaques in interferon-competent cells in culture (
24,
25). Regardless of their ability to regulate IFN secretion later during infection, rotavirus infection likely triggers a conserved signaling pathway early in infection, resulting in activation of IRF3, NF-κB-dependent VSIGs, and possibly IFN itself (
26). We and others have found that early during infection, both RRV and UK RVs activate the cytosolic PRRs RIG-I and MDA-5 in a replication-dependent manner, and subsequent signaling mediated through the mitochondrial adaptor MAVS results in induction of several IRF3- and NF-κB-dependent VSIGs and IFNs (
20,
23,
27–33). However, at later times during infection (16 to 24 h postinfection [hpi]), RRV more effectively prevents IFN secretion than UK RV. Unlike UK NSP1, RRV NSP1 degrades murine IRF3 and inhibits its transcriptional activity at a stage following the phosphorylation of IRF3 at its carboxyl terminus (
23). The inability of UK NSP1 to degrade murine IRF3 in murine fibroblasts is not an inherent defect in the protein but is dependent on the IRF3 protein encoded by the host cell. UK NSP1 degrades the endogenous IRF3 expressed in simian COS7 cells, and simian IRF3 can also be efficiently degraded by UK NSP1 when transiently expressed in mouse embryonic fibroblasts (MEFs) (
23). Other studies have shown that NSP1 degrades additional IRFs, including IRF5 and IRF7 (
22,
25), indicating that apart from IRF3-dependent IFN induction, other IRF-specific responses may also be regulated by rotavirus during infection. Previous studies have also described NSP1-mediated inhibition of IFN induction by inhibition of RIG-I (
31) and inhibition of poly(I·C)-directed IRF3-dependent transcription in the absence of any IRF3 degradation (
23). Thus, the inhibition of IRF3 function by rotaviruses may involve both degradation-dependent and degradation-independent mechanisms.
Interestingly, certain rotavirus strains encode an NSP1 that fails to direct IRF3 degradation or inhibition (
22,
29). The NSP1 proteins from several of these strains inhibit IFN induction by targeting the NF-κB pathway. Graff and coworkers (
29) demonstrated that porcine rotavirus OSU NSP1 is unable to degrade IRF3 but interacts with and degrades β-TrCP, an essential cofactor in IκB-α degradation and consequent NF-κB activation. The NSP1 protein of still other RV strains may inhibit IFN induction by interacting with beta transducin repeat-containing protein (β-TrCP), but without causing its degradation, in a manner reminiscent of the A49 protein of vaccinia virus (
34; M. Morelli and J. T. Patton, personal communication). In addition, certain rotaviruses sequester the NF-κB p65 subunit in viroplasms during infection (
30), potentially blocking NF-κB signals in a β-TrCP-independent manner. Although the viral factors and mechanisms used in β-TrCP degradation-independent inhibition of NF-κB transcriptional activity have yet to be determined, it is likely that rotavirus inhibition of NF-κB-dependent innate signaling is critical for inhibition of the innate immune response in murine villous intestinal epithelial cells (IECs)
in vivo (
20). STAT1-deficient suckling mice can induce IFN normally but lack secondary IFN-mediated responses; in these mice, infection with murine EW results in significantly lower NF-κB-dependent transcription and increased IκB-α protein levels in the intestine at 16 hpi compared to infection with simian RRV (
20).
Recently, using a single-cell analytical approach, we observed that EW murine RV prevents the induction of IFN transcripts in both infected and bystander villous IECs
in vivo despite robust IFN induction in resident intestinal hematopoietic cells (
20). In IECs from 5-day-old suckling mice infected with the EW strain of murine rotavirus for 16 h, NF-κB-dependent activation of VSIG transcription was absent, but IRF3-dependent VSIG transcription was detected, indicating that EW regulates NF-κB activity in the intestinal epithelium. Interestingly,
in vitro, the EW NSP1 protein effectively degrades IRF3 in fibroblasts to inhibit IFN induction, likely after phosphorylation in the carboxyl-terminal region of IRF3 (
23). Thus, rotavirus regulation of IRF3 and NF-κB may be more complex than previously appreciated and is likely dependent on several factors, including timing during infection and the type of cell infected. Regardless of the manner in which IFN induction is inhibited, the finding that homologous RV replicates in the epithelium of the murine intestine to high levels despite robust IFN induction in local hematopoietic cells argues that (i) rotaviruses likely block antiviral signaling in response to exogenous IFN and (ii) such virus-mediated inhibition likely also occurs in bystander uninfected epithelial cells.
Recently, Holloway et al. (
30) demonstrated that early in rotavirus infection, STAT1 function is inhibited by a conserved mechanism that allows STAT1-Y701 activation in response to exogenous IFN-mediated signaling but prevents its subsequent nuclear localization. That study did not identify a role for individually expressed NSP1, NSP3, or NSP4 in RV-mediated STAT1 functional inhibition. Since secondary responsiveness and transcription of ISGs through exogenous stimulation of IFN receptors in both infected (autocrine) and bystander (paracrine) cells are critically dependent on the phosphorylation of STAT1 at Y701, it seemed plausible that rotaviruses not only have evolved functions to inhibit IRF3 and NF-κB activation but also might effectively prevent IFN-mediated STAT1 signaling in both infected and bystander intestinal epithelial cells. Here we report that rotavirus infection does effectively suppress exogenous IFN-directed STAT1 activation in both infected and bystander IECs late in infection and identify rotavirus NSP1 as an antagonist of IFN-mediated STAT1 Y701 phosphorylation. Our findings help explain the previously observed regulation of the host IFN response in the intestine
in vivo (
20) and reveal a novel function of NSP1 as a STAT1 antagonist.
DISCUSSION
During infection, rotavirus inhibits the induction of IFN by blocking the function of either IRF3 or NF-κB; in the majority of strains studied to date, NSP1 proteins mediate IRF3 degradation (
22,
26). Our present data (
Fig. 1A) indicate that in HT29 human intestinal epithelial cells, porcine RV SB1A mediated β-TrCP degradation as early as 6 hpi. In contrast, infection with simian RRV did not result in altered β-TrCP levels but instead led to a reduction of IRF3 levels. The difference in β-TrCP levels at 6 hpi correlated well with the ability of SB1A, but not RRV, to inhibit IκB-α degradation in response to exogenous TNF-α stimulation (
Fig. 1B and
C). Despite these differences, we did not find a significant difference between RRV and SB1A (or the closely related porcine OSU strain) in their abilities to regulate IFN secretion at 16 hpi (
Fig. 3D). Therefore, in HT29 cells, RRV and SB1A appear to employ mutually exclusive, but equally effective, strategies for targeting IRF3 and NF-κB function at 6 hpi to regulate the induction of IFN.
Although rotaviral inhibition of the IFN induction pathways has been examined in several studies, comparatively little is known about the manner in which different strains might regulate innate responses to exogenous IFN. It is estimated that one infectious particle of homologous RV can lead to full-blown diarrheal disease and extensive viral replication in wild-type suckling mice with intact type I, II, and III IFN responses (
13). This remarkable lack of sensitivity of homologous RV to the host IFN responses, along with substantial induction of IFN in local hematopoietic cells during viral replication in the intestinal villous epithelium (
20), strongly supports the hypothesis that RV might also possess strategies to subvert innate responses in infected and bystander epithelial populations that are exposed to IFN.
Following binding to their cognate receptor, type I IFNs induce tyrosine phosphorylation of STAT1 and STAT2, which form a trimolecular complex together with IRF9, called ISGF3. This complex binds to the ISREs in several ISGs (
9). The phosphorylation of STAT1 on Y701 is essential for formation of the ISGF3 complex and subsequent antiviral gene transcription (
8). Like type I IFN, type III IFNs exert their primary antiviral activity through the pY701-STAT1/ISGF3 axis (
5). The formation of STAT1 homodimers following tyrosine phosphorylation is also pivotal in the transcriptional response of GAS promoter-containing genes following stimulation of the type II IFN receptor (
38). Thus, the antiviral response downstream of several IFN subtypes is dependent on phosphorylation of STAT1 at Y701 (
39). Therefore, we first examined the ability of the porcine SB1A and simian RRV RV strains to inhibit pY701-STAT1 activation in response to exogenous IFN stimulation early in infection (6 hpi) (
Fig. 2). Although by 6 hpi, both SB1A and RRV had depleted their respective IFN induction mediators, β-TrCP and IRF3 (
Fig. 1A), neither virus significantly inhibited exogenous IFN-mediated STAT1 phosphorylation in infected or uninfected bystander cells at this stage of infection (
Fig. 2). In the absence of exogenous pathway stimulation, tyrosine phosphorylation was not detected in bystander cells from SB1A- or RRV-infected cultures (as might be expected if substantial and sustained IFN secretion was present in the cultures at 6 hpi) (
Fig. 2), suggesting that at 6 hpi, RV encodes effective strategies to avoid the activation of STAT1 in bystander cells.
In our experiments, we observed that both RRV and SB1A weakly inhibited phosphorylation of STAT1 at Y701 at 6 hpi in infected and bystander populations, but these effects were considerably amplified at 16 hpi (
Fig. 3C), suggesting that inhibition of IFN-mediated STAT1 phosphorylation is most effective at later times during infection. It was previously reported that at 6 hpi, RV-infected cells prevent STAT1 and STAT2 nuclear localization following exogenous IFN stimulation (
30). Thus, in addition to the induction and release of exogenous IFN, at 6 hpi, RV may interfere with STAT1 function by blocking its nuclear localization, a step that occurs subsequent to Y701 activation. Although the viral and host factors involved in this early regulation of STAT by RV are currently unknown, our results offer some insight into this process. A subpopulation of SB1A-infected cells displayed abnormally elevated levels of pY701-STAT1 at 6 hpi (
Fig. 2 and
6), and this activation was similarly sustained through 16 hpi (
Fig. 3). Interestingly, the level of pY701-STAT1 activation was highest in those cells that stained strongly for VP6, supporting the conclusion that STAT1 activation is an effect of SB1A replication rather than IFN receptor activation. In contrast, ∼50% of SB1A-infected cells did not contain detectable STAT1 activation and exhibited a continuum in their expression levels of VP6. How a significant proportion of SB1A-infected cells at 16 h avoid STAT1 activation despite exogenous IFN stimulation is an interesting question raised by our results. The absence of further activation of pY701 in the two SB1A-infected cell subpopulations as well as in bystander cells at later times following stimulation with increasing doses of IFN, as well as comparable levels of secreted IFN in unstimulated infected cells at 16 h (
Fig. 3), demonstrates the effectiveness of this viral strategy in preventing IFN-mediated STAT1 signaling and subsequent STAT1-dependent IFN amplification. Identification of the mechanisms underlying SB1A regulation of STAT1 activation, including the effect of β-TrCP-degrading NSP1 proteins on STAT1 signaling, will require further experiments.
In clear contrast to findings early during rotavirus infection, at 16 hpi, we found that RV-infected cells effectively resist exogenous IFN-mediated pY701-STAT1 activation (
Fig. 3). In the absence of any exogenous stimulation, pY701-STAT1 expression in bystander cells of RRV- or SB1A-infected monolayers was comparable to levels in mock-infected cells (
Fig. 3A) and similar to findings at 6 hpi (
Fig. 2A). However, in approximately 50% of infected cells, SB1A induced STAT1 tyrosine phosphorylation to levels approaching those observed following stimulation of uninfected HT29 cells with 2,000 U/ml of exogenous IFN-β (
Fig. 3A); levels in the remainder of SB1A-infected cells, as well as in all RRV-infected cells, were significantly lower and were similar to pY701-STAT1 staining in resting mock-infected HT29 cells. These differences between SB1A- and RRV-induced pY701-STAT1 were observed at both 6 hpi and 16 hpi, suggesting that SB1A infection leads to early activation of STAT1 exclusively within a subset of infected cells, and this activation is sustained later during infection. At 16 hpi, when cells were exogenously stimulated with increasing doses of IFN-β, neither SB1A- nor RRV-infected cells displayed an appreciable increase in pY701-STAT1 activation over baseline levels in their respective unstimulated populations (
Fig. 3C). Thus, in contrast to the inability of RRV to inhibit IFN-mediated STAT1 activation at 6 hpi, at a later time postinfection, RRV infection efficiently suppressed the exogenous IFN signaling pathway. Sustained activation of pY701-STAT1, which was observed among SB1A-infected HT29 cells, has been associated with antiapoptotic and proliferative effects in the context of oncogenic viruses, such as acute myeloid lymphoma and Epstein-Barr virus-associated malignancies (
39). It will be of interest to determine whether SB1A-induced STAT1 activation results in similar antiapoptotic functional consequences during infection.
An intriguing finding from our study is that although SB1A VP6
− cells (bystanders) responded to exogenous IFN stimulation at 6 hpi (
Fig. 2), by 16 hpi, they were completely refractory to pathway stimulation (
Fig. 3C), irrespective of the IFN dose. This phenomenon was also observed following infection with SOF, an SA11-derived monoreassortant strain encoding porcine OSU NSP1. A similarly significant, but weaker, effect was observed in RRV bystander cells at 16 hpi as well (
Fig. 3B). These results suggest that rotavirus infection not only is able to directly inhibit the phosphorylation of pY701-STAT1 in infected cells but also can effectively mediate such inhibition in uninfected (i.e., VP6-negative) cells late in infection. The fact that pY701-STAT1 activation is not inhibited at early times postinfection (6 hpi) in either VP6-positive or -negative cells, and the potent repression of Y701 in SB1A and SOF VP6-negative cells, even at high doses of IFN-β, suggests that the factor(s) that mediates this effect originates from infected cells between 6 and 16 hpi. Similar remote effects of RV infection on bystander interferon responses were recently observed in suckling mice infected with the EW strain of murine RV (
20). No amplification of IFN transcripts was observed in bystander villous IECs in these mice, despite exogenous IFN induction in the intestinal hematopoietic cell compartment. The finding that SOF, but not the closely related strains SRF and SA11, is able to mediate such inhibition in VP6-negative HT29 cells (
Fig. 6) strongly supports the conclusion that NSP1 plays a role in influencing the ability of bystander IECs to respond to IFN. Alternately, several cytokines and at least one RV nonstructural protein, NSP4, are released from RV-infected IECs and could also potentially mediate remote inhibition of STAT1 signaling (
40,
41). We are currently investigating the nature of the RV-mediated signal that regulates IFN responsiveness in bystander (uninfected) cells.
Most RV strains studied to date degrade IRF3 rather than β-TrCP during infection to subvert IFN induction (
22). Our results demonstrate that cells infected with the IRF3-degradative strain RRV effectively inhibit activation of Y701 on STAT1 in response to the presence of exogenous IFN. Since innate immune responses mediated by several different IFN subtypes (types I, II, and III) converge at this critical signaling step, identification of the viral factor(s) that mediates the inhibition of Y701 phosphorylation is crucial to an understanding of the basis for rotavirus resistance/sensitivity to the host interferon response. A likely candidate for inhibition of STAT1 phosphorylation on Y701 was NSP1, whose cognate gene (gene 5) cosegregates with STAT1- and IFN-receptor-dependent replication and virulence phenotypes
in vivo and
in vitro (
13–16,
23). In order to examine a possible role for NSP1 in STAT1 inhibition, we expressed the NSP1 proteins from three rotavirus strains (simian RRV, bovine UK, and murine EW) that share the common property of IRF3 degradation in HT29 cells (
22) as GFP-tagged fusion proteins (
23). Previous studies reported that NSP1 is a poorly expressed protein due to inefficient recruitment of ribosomes on NSP1 transcripts (
42) and due to posttranslational NSP1 proteasomal degradation (
23,
37,
43). Therefore, we chose a single-cell analytical approach to directly compare the pY701-STAT1 status within NSP1-expressing cells in the presence or absence of exogenous stimulation (
Fig. 4). When pY701-STAT1 activation in response to IFN stimulation was measured in cells expressing NSP1 by flow cytometry, we found that the NSP1 proteins encoded by RRV, UK, and EW effectively inhibited the STAT1 pathway (
Fig. 4B and
C). Our data also demonstrate that porcine OSU NSP1 is capable of inhibiting IFN-mediated STAT1 activation within infected cells in the context of other viral proteins (
Fig. 6). Whether porcine NSP1 proteins expressed by themselves are similarly functional will require further studies.
Although the 55-kDa NSP1 protein sequences from different rotavirus strains are highly divergent, all RV NSP1 proteins examined to date contain an N-terminal RING finger motif with conserved spacing of the predicted divalent cation coordinating cysteine and histidine sites (
26). Mutagenesis of C59 and H63 of RRV NSP1, in the second and first predicted Zn-binding sites of this domain, respectively, resulted in an NSP1 mutant whose expression was MG132 sensitive and hence not significantly less unstable than the wild-type protein in COS7 cells (
Fig. 5B). However, proteasomal degradation of IRF3 was completely abolished in COS7 cells that expressed mutant, but not wild-type, NSP1 (
Fig. 5C and
D). These results are in agreement with previous observations that disruption of residues within the RING motif led to diminished IRF3 interaction and degradation (
37). On the other hand, the RRV RING finger mutant retained the ability to inhibit IFN-mediated pY701-STAT1 activation in HT29 cells (
Fig. 5E and
F). Therefore, the ability of NSP1 to inhibit IFN induction versus IFN signaling pathways appears to be encoded by discrete domains of the protein. In our experiments using the SA11 reassortants SRF and SOF, expression of OSU (but not SA11 or RRV) NSP1 in the SA11 genetic background significantly altered the ability of “bystander” (i.e., non-VP6-expressing) cells to respond to exogenous IFN stimulation (
Fig. 6), indicating that certain NSP1 proteins and/or host factors regulated by their expression during virus infection may mediate the remote effect on STAT1-Y701 signaling observed at 16 hpi (
Fig. 3). However, transient expression of NSP1 encoded by the RRV, EW, or UK strain did not significantly alter STAT1 activation in NSP1
− cells (
Fig. 4 and
5), indicating that these NSP1 proteins are unable to direct STAT1 inhibition in bystander cells. In contrast, both SOF and transiently expressed RRV/EW/UK NSP1 proteins similarly inhibited Y701-STAT1 phosphorylation directly within cells that were either VP6
+ or NSP1
+, respectively. We plan to examine whether NSP1 encoded by the SB1A and/or OSU strain is sufficient to inhibit IFN-mediated STAT1 signaling in NSP1
− populations in future studies. Since NSP1 mediates both the depletion of β-TrCP/IRF3 (
25,
29) and the inhibition of IFN-directed STAT1 activation (
Fig. 4 and
5), which occur at distinct times during infection, we hypothesize that the various NSP1 functions taking place during the course of infection may be subject to currently unknown temporal regulatory mechanisms that determine pathway-specific inhibition.
The ability of RV to regulate STATs was first observed by Holloway and coworkers, who found that RV blocks type I and II IFN-induced gene expression by preventing nuclear accumulation of STAT1 and STAT2 (
30). In that study, at 2 to 12 hpi, simian RRV and human Wa RVs failed to inhibit Y701-STAT1 phosphorylation mediated by exogenous IFN-α. In contrast, human Wa RV was shown to activate pY701-STAT1 in the absence of exogenous stimulation, and this effect was ascribed to IFN induced during Wa infection (
30). Both RRV and Wa effectively prevented nuclear accumulation of STAT1 and STAT2 in response to exogenous IFN stimulation at 6 hpi based on immunomicroscopy of total STAT proteins. Finally, RRV nonstructural proteins NSP1, NSP3, and NSP4 did not inhibit expression from an ISRE-luciferase reporter following the addition of exogenous IFN-α.
Our experimental approach differs from the previous study (
30) in several important ways that could account for the apparently contradictory results. Holloway et al. examined averaged effects in monolayers of cells infected with rotavirus to determine whether an inhibition of exogenous IFN-mediated STAT1-Y701 phosphorylation occurs during the 2- to 12-hpi time frame. We found that following infection with either RRV or SB1A, inhibition of pY701-STAT1 in response to stimulation did not occur until 16 hpi and then only within specific subpopulations of HT29 cells (
Fig. 3). Thus, RV effects on STAT1 activation are most readily apparent when STAT status is assessed at the single-cell level. In the study by Holloway et al. (
30), the ability of nonstructural proteins to inhibit STAT1-mediated transcription was assessed by using an “averaged” rather than a single-cell signal approach. Despite these differences, our results are in general agreement with the observations by Holloway et al. (
30), including the inability of RV at 6 hpi to inhibit the activation of pY701-STAT1 in response to IFN and the activation of pY701-STAT1 by some RV strains in the absence of any exogenous IFN stimulation.
The two discrete innate immunity-inhibitory functions of rotavirus NSP1 allow it to effectively inhibit both host IFN induction and amplification signaling pathways. Previous studies uncovered an NSP1-dependent phenotype for rotavirus replication, as assessed by both viral titer and plaque size, reflecting the ability of NSP1 to regulate virus growth and subsequent spread to adjacent bystander cells (
26). Initial infection of epithelial cells at a low MOI occurs only in a subset of cells, resulting in the activation of early IFN induction signaling pathways, the expression of subsets of VSIGs (
20), and some level of IFN secretion (
27,
33).
In vivo, RV infection also resulted in a robust IFN response in the nonepithelial hematopoietic cell compartment (
20). The finding that inhibition of both IFN secretion and IFN-mediated signaling converge on the NSP1 protein indicates that it is a multipurpose viral antagonist of the host innate immune response. Thus, NSP1 is a viral factor that is capable of inhibiting the IFN induction pathway in different cell types by targeting cell-type-specific IRFs and of negating the antiviral effects of the multiple downstream IFNs (types I, II, and III) that rely on successful tyrosine activation of STAT1.
Several interesting questions are raised by our findings. The mechanism by which SB1A regulates STAT1 signaling and the identities of remote inhibitory factors that influence STAT1 signaling in uninfected bystander cells remain to be determined. Our data, when combined with recent observations that a robust early innate response correlates with live attenuated vaccine immunogenicity (
44,
45), suggest that it might be possible to further enhance reassortant rotavirus vaccine strain immunogenicity by diminishing the ability of the strains to inhibit innate responses by incorporating a relevant NSP1 gene.